...
首页> 外文期刊>Circulation journal >Fasting and Non-Fasting Triglycerides and Risk of Cardiovascular Events in Diabetic Patients Under Statin Therapy
【24h】

Fasting and Non-Fasting Triglycerides and Risk of Cardiovascular Events in Diabetic Patients Under Statin Therapy

机译:禁食和非禁食甘油三酯和糖尿病患者患者的心血管事件风险

获取原文
           

摘要

Background: Few data specifically investigate associations between fasting/non-fasting triglycerides (TG) and cardiovascular (CV) events under statin therapy among Japanese diabetic patients. Methods?and?Results: We recruited 4,988 participants with diabetes from the EMPATHY study. Median follow-up was 3 years. We evaluated associations between serum fasting/non-fasting TG and first CV events in Cox-regression hazard models adjusted by classical risk factors. CV events were defined as (1) major adverse cardiac events (MACE) including myocardial infarction, stroke, or cardiac death; and (2) CV diseases (CVD) including myocardial infarction, unstable angina, ischemic stroke, or large artery disease or peripheral arterial disease. Fasting as well as non-fasting TG were associated with MACE (adjusted hazard ratio [HR]: 1.017 per 10 mg/dL; 95% confidence interval [CI]: 1.000–1.037; P=0.046, adjusted HR: 1.028 per 10 mg/dL; 95% CI: 1.006–1.050; P=0.0091) and CVD (adjusted HR: 1.024 per 10 mg/dL; 95% CI: 1.011–1.038; P=4.4×10sup?3/sup, adjusted HR: 1.028 per 10 mg/dL; 95% CI: 1.010–1.046; P=4.9×10sup?3/sup). Comparing the top quartile with the bottom quartile of non-fasting TG, adjusted HR significantly increased 5.18 (95% CI: 1.38–18.3, P=0.014) for MACE, and 2.40 (95% CI: 1.11–4.75, P=0.021) for CVD, while adjusted HR did not change when divided into quartile of fasting TG. Conclusions: Non-fasting TG could be considered as a substitute for fasting TG as a risk stratification for future CV events among Japanese diabetic patients.
机译:背景:少数数据专门研究日语糖尿病患者的禁食/非禁食甘油三酯(TG)和心血管(CV)事件之间的关联。方法?结果:我们招募了4,988名参与者与同理心研究的糖尿病。中位后续时间为3年。我们评估了通过经典风险因素调整的Cox-返回危险模型中血清禁食/非禁食TG和第一CV事件之间的关联。 CV事件被定义为(1)主要不良心脏事件(立柱),包括心肌梗死,中风或心脏死亡; (2)CV疾病(CVD),包括心肌梗死,不稳定的心绞痛,缺血性卒中或大动脉疾病或外周动脉疾病。禁食以及非禁食TG与芯片有关(调整后的危险比[HR]:1.017每10 mg / dL; 95%置信区间[CI]:1.000-1.037; P = 0.046,调整为每10毫克:1.028 / DL; 95%CI:1.006-1.050; p = 0.0091)和CVD(调节的HR:每10 mg / dl; 95%CI:1.011-1.038; P = 4.4×10 ?3 ,调整后的HR:每10 mg / dL 1.028; 95%CI:1.010-1.046; p = 4.9×10 ?3 )。将顶部四分位与非禁食TG的底部四分位数进行比较,调整后的HR显着增加5.18(95%CI:1.38-18.3,P = 0.014),2.40(95%CI:1.11-4.75,P = 0.021)对于CVD,当调整后的HR除以禁食TG的四分位数时没有改变。结论:非禁食TG可被视为禁食TG作为日本糖尿病患者未来CV事件的风险分层的替代品。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号